Joseph Frattaroli
Keine laufenden Positionen mehr
Vermögen: 17 312 $ am 31.03.2024
Profil
Joseph Frattaroli is the founder of Flagship Consulting, Inc. (founded in 2010).
He was the President, Chief Executive & Financial Officer at Vaso Active Pharmaceuticals, Inc. from 2009 to 2012.
He is currently the Chief Financial Officer at Inhibikase Therapeutics, Inc. (2018-2024).
Mr. Frattaroli obtained his undergraduate degree from Salem State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.03.2024 | 8 015 ( 0,13% ) | 17 312 $ | 31.03.2024 |
Ehemalige bekannte Positionen von Joseph Frattaroli
| Unternehmen | Position | Ende |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Director of Finance/CFO | 31.03.2024 |
Vaso Active Pharmaceuticals, Inc.
 Vaso Active Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vaso Active Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The Company focuses on vaso active lipid encapsulated or VALE, transdermal delivery technology drugs. Currently, they market Athlete's Relief and Osteon in the United States. The Company's products, include Analgesics, Toenail fungal treatment, Acne, First aid, Hand and body lotion and Psoriasis treatment. It is planning to rebrand the deFEET athlete's foot anti-fungal medication product as Termin8 and Xtinguish. | Director of Finance/CFO | 06.11.2012 |
| Flagship Consulting, Inc. | Founder | - |
Ausbildung von Joseph Frattaroli
| Salem State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Vaso Active Pharmaceuticals, Inc.
Vaso Active Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vaso Active Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The Company focuses on vaso active lipid encapsulated or VALE, transdermal delivery technology drugs. Currently, they market Athlete's Relief and Osteon in the United States. The Company's products, include Analgesics, Toenail fungal treatment, Acne, First aid, Hand and body lotion and Psoriasis treatment. It is planning to rebrand the deFEET athlete's foot anti-fungal medication product as Termin8 and Xtinguish. | Health Technology |
| Flagship Consulting, Inc. |
